Advertisement

Topics

World Federation of Hemophilia (WFH) Company Profile

21:07 EDT 21st September 2017 | BioPortfolio

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963, it is a global network of patient organizations in 113 countries and has official recognition from the World Health Organization. Visit WFH online at www.wfh.org.


News Articles [883 Associated News Articles listed on BioPortfolio]

EpiCast Report: Hemophilia Epidemiology Forecast to 2026 [Report Updated: 01072017] Prices from USD $3995

EpiCast Report: Hemophilia Epidemiology Forecast to 2026SummaryHemophilia is an Xlinked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the pro...

World Obesity Federation recognizes obesity as chronic, relapsing disease

In a statement published today in the leading journal Obesity Reviews, the World Obesity Federation confirms its support for defining obesity as a chronic, relapsing disease.

Hundreds Gather at National AIDS Memorial to Dedicate Newly Built Hemophilia Memorial Circle to Honor Lives Lost in Early Days of AIDS Epidemic

SAN FRANCISCO, Sept. 16, 2017 /PRNewswire-USNewswire/ -- Hundreds of hemophilia advocates and survivors came together at the National AIDS Memorial to dedicate the Hemophilia Memorial Circle, a b...

New Data to be Presented at ISTH Underscore Bioverativ's Commitment to Advance Hemophilia Care

19 hemophilia-related abstracts will be presented, demonstrating the company's commitment to innovation and addressing serious unmet patient needs in hemophilia Bioverativ Inc. (NASDAQ: BIVV), a g...

Pfizer Signs On For Sangamo’s Hemophilia A Gene Therapy

Pfizer has turned again to external expertise among US biotechs to find a potential gene therapy for hemophilia A, to...   

New Data to be Presented at ISTH Underscore Bioverativ’s Commitment to Advance Hemophilia Care

Thursday, July 6th 2017 at 11:05am UTC 19 hemophilia-related abstracts will be presented, demonstrating the company’s commitment to innovation and addressing serious unmet patient needs in hemophili...

Global Hemophilia Therapeutics Market By Drug, By Type of Hemophilia, By Treatment, By Therapy Outlook 2022

LONDON, May 31, 2017 /PRNewswire/ -- Hemophilia is an inherited bleeding disorder that slows the blood clotting process. The people suffering from this condition experience prolonged bleeding due to t...

Shire, MicroHealth to address hemophilia A and B patient needs

Shire, a biotech leader in rare diseases, announced a collaboration with MicroHealth to support a free and secure care monitoring tool for hemophilia A and B patients with inhibitors and their care te...

Clinical Trials [1166 Associated Clinical Trials listed on BioPortfolio]

World Bleeding Disorders Registry

The World Federation of Hemophilia (WFH) is conducting the pilot phase of an international, retrospective and prospective, observational, World Bleeding Disorders Registry (WBDR). This pil...

Study Evaluating ReFacto in Hemophilia A

To identify the causative mutations in previously untreated patients with hemophilia A enrolled in the ReFacto® clinical safety and efficacy study CTN 93-R833-0XX/C9741-28, using two esta...

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

To collect and analyze data on females with hemophilia so as to better define the difference between the study population and the male population with hemophilia.

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

To correlate the HLA type and genetic defect with hemophilia A.

Epidemiology and Immunology of Hemophilia A Inhibitors

To determine the risk factors associated with inhibitor formation in hemophilia A and to study the mechanism of tolerance in the murine hemophilia A model.

Companies [685 Associated Companies listed on BioPortfolio]

World Federation of Hemophilia (WFH)

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and related bleeding disorders. Established in 1963,...

World Federation of Hemophilia

The World Federation of Hemophilia (WFH) is an international not-for-profit organization dedicated to improving the lives of people with hemophilia and other inherited bleeding di...

Hemophilia Federation of America

NORSK INDUSTRI

On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...

The National Hemophilia Foundation

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and to preventing the complications of these disorders through education,...

More Information about "World Federation of Hemophilia (WFH)" on BioPortfolio

We have published hundreds of World Federation of Hemophilia (WFH) news stories on BioPortfolio along with dozens of World Federation of Hemophilia (WFH) Clinical Trials and PubMed Articles about World Federation of Hemophilia (WFH) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of World Federation of Hemophilia (WFH) Companies in our database. You can also find out about relevant World Federation of Hemophilia (WFH) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record